Oxyfedrine

Jump to: navigation, search
Oxyfedrine
Oxyfedrine.png
Clinical data
ATC code
Identifiers
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC19H23NO3
Molar mass313.39 g/mol

WikiDoc Resources for Oxyfedrine

Articles

Most recent articles on Oxyfedrine

Most cited articles on Oxyfedrine

Review articles on Oxyfedrine

Articles on Oxyfedrine in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Oxyfedrine

Images of Oxyfedrine

Photos of Oxyfedrine

Podcasts & MP3s on Oxyfedrine

Videos on Oxyfedrine

Evidence Based Medicine

Cochrane Collaboration on Oxyfedrine

Bandolier on Oxyfedrine

TRIP on Oxyfedrine

Clinical Trials

Ongoing Trials on Oxyfedrine at Clinical Trials.gov

Trial results on Oxyfedrine

Clinical Trials on Oxyfedrine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Oxyfedrine

NICE Guidance on Oxyfedrine

NHS PRODIGY Guidance

FDA on Oxyfedrine

CDC on Oxyfedrine

Books

Books on Oxyfedrine

News

Oxyfedrine in the news

Be alerted to news on Oxyfedrine

News trends on Oxyfedrine

Commentary

Blogs on Oxyfedrine

Definitions

Definitions of Oxyfedrine

Patient Resources / Community

Patient resources on Oxyfedrine

Discussion groups on Oxyfedrine

Patient Handouts on Oxyfedrine

Directions to Hospitals Treating Oxyfedrine

Risk calculators and risk factors for Oxyfedrine

Healthcare Provider Resources

Symptoms of Oxyfedrine

Causes & Risk Factors for Oxyfedrine

Diagnostic studies for Oxyfedrine

Treatment of Oxyfedrine

Continuing Medical Education (CME)

CME Programs on Oxyfedrine

International

Oxyfedrine en Espanol

Oxyfedrine en Francais

Business

Oxyfedrine in the Marketplace

Patents on Oxyfedrine

Experimental / Informatics

List of terms related to Oxyfedrine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Oxyfedrine is a vasodilator. Oxyfedrine was found to depress the tonicity of coronary vessels, improve myocardial metabolism (so that heart can sustain hypoxia better) and also exert a positive chronotropic and inotrophic effects, thereby not precipitating angina pectoris. The latter property (positive chronotropic and inotrophic effects) is particularly important, because other vasodilators used in angina may be counter productive causing coronary steal phenomenon.

Synergestic effects with antibiotics have been suggested.[1]

References

  1. Mazumdar, Kaushiki (2005-04). "In vitro and in vivo synergism between tetracycline and the cardiovascular agent oxyfedrine HCl against common bacterial strains". Biological & Pharmaceutical Bulletin. 28 (4): 713–717. ISSN 0918-6158. PMID 15802815. Unknown parameter |coauthors= ignored (help); Check date values in: |date= (help)

Linked-in.jpg